Provention Investor Sues To Stop $2.9B Sanofi Merger
By George Woolston ( April 4, 2023, 3:04 PM EDT) -- A Provention Bio Inc. investor has filed a lawsuit seeking to delay the biopharmaceutical company's pending $2.9 billion equity merger with Sanofi SA until it explains the deal's financial justification and alleged conflicts of interest — information that was purportedly concealed in filings and regulatory filings encouraging shareholders to accept a tender offer....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.